<DOC>
	<DOCNO>NCT01593787</DOCNO>
	<brief_summary>This study assess safety , tolerability , efficacy LCZ696 hypertensive patient renal dysfunction .</brief_summary>
	<brief_title>Safety Tolerability Efficacy LCZ696 Japanese Hypertensive Patients With Renal Dysfunction</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>LCZ 696</mesh_term>
	<criteria>Renal finding : Hypertensive patient renal dysfunction stable renal condition least 4 week screen visit . Satisfy office msSBP ≥140 mmHg &lt; 180 mmHg baseline . Patients show msDBP ≥110 mmHg and/or msSBP ≥180 mmHg . History angioedema , drugrelated otherwise , report patient . Any following renal disorder : Patients show eGFR &lt; 15mL/min/1.73m^2 Patients dialysis Patients previously enter LCZ696 study randomize enrolled active drug treatment epoch . Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>Renal dysfunction</keyword>
	<keyword>LCZ696</keyword>
</DOC>